Imagine the thought Leo and Dr. M have put into the company over the last 5-6 years and how they must decide how it will proceed into the future. It is a part of them, something they will forever be forged with as one.

I am sure their priorities are as follows:

1. Helping the most patients as quickly as possible.
2. Rewarding shareholders as greatly as possible.
3. Thinking of themselves and the benefits to them.

As an aside, I am somewhat shocked at the validity given a number of drugs only in pre-clinical to ongoing Phase1 and how little has been delved into our products which are much further down the path to commerciality (or more importantly availability) and the outstanding safety profile each of them possess. IPIX really is going to explode on the world when it is our time to release all the news as right now it sure seems to be contained in a tight little cocoon of medical eyes and stockholders.